Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Latest research on diagnosis and treatment of allergic diseases

Researchers are presenting more than 450 abstracts on investigational findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Seattle, Nov. 6-11. Following are highlights of some key studies on asthma.

11 Nov 2008

New advances in diagnosis and treatment of allergic diseases

11 Nov 2008

Struggling with incontinence? seek help

More than 15 million Americans, primarily women, suffer from incontinence.

11 Nov 2008

Diabetes and foot problems

Bradford Miller has had diabetes for nine years, and he knows the importance of quick treatment for related problems such as swelling and numbness in the feet.

11 Nov 2008

Another outbreak of bird flu in Thailand has authorities on high alert

A dead chicken on a backyard farm in northern Thailand has signalled another outbreak of bird flu and comes six months after the country declared itself free of the disease.

11 Nov 2008

1918 Spanish flu records could hold the key to solving future pandemics

Ninety years after Australian scientists began their race to stop the spread of Spanish flu in Australia, University of Melbourne researchers are hoping records from the 1918 epidemic may hold the key to preventing future deadly pandemic outbreaks.

10 Nov 2008

Flu shots cut the risk of blood clots forming in veins

According to new research by French scientists flu shots may reduce the risk of venous thrombotic embolism.

10 Nov 2008

T-cell-based strategy for HIV-1 vaccines still viable option

The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.

10 Nov 2008

Xolair (Omalizumab) shows promise in treating allergic asthma inadequately controlled by inhaled corticosteroid

Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.

10 Nov 2008

New hybrid technology for disease prevention

The earlier cancer is diagnosed, the better the chance of effecting a cure.

10 Nov 2008

Heart failure hospitalization rates rise among nation's seniors

Heart failure is reaching epidemic levels among seniors in the United States, according to research presented at the American Heart Association's Scientific Sessions 2008.

10 Nov 2008

Flu shots may reduce risk of blood clots forming in veins

Flu shots may reduce the risk of blood clots forming in veins by 26 percent, according to research presented at the American Heart Association's Scientific Sessions 2008.

10 Nov 2008

Bullies love to bully

The researchers from the University of Chicago used functional Magnetic Resonance Imaging (fMRI) scans of eight 16 to 18 year-old boys with aggressive conduct disorder and compared them to eight matched adolescents without conduct disorder.

9 Nov 2008

Superbugs on the rise in Canadian hospitals

Although infection control has been substantially ramped up in Canadian hospitals since the SARS crisis of 2003, the number of resistant bacterial infections post-SARS have multiplied even faster, a new Queen's University study shows.

8 Nov 2008

Number of custodial grandparents in U.S. has nearly doubled since 1970

Precautionary health measures such as mammograms and cholesterol tests that identify the risk of heart disease are critical for the well-being of women over 50.

7 Nov 2008

GSK initiates major seasonal influenza vaccine efficacy trial

GlaxoSmithKline (GSK) announced today that it has started a worldwide clinical efficacy trial to evaluate an innovative vaccine for the prevention of seasonal influenza.

6 Nov 2008

H5N1 protein hides in tiny tubules

A protein found in the virulent avian influenza virus strain called H5N1 forms tiny tubules in which it "hides" the pieces of double-stranded RNA formed during viral infection, which otherwise would prompt an antiviral immune response from infected cells, said Baylor College of Medicine researchers in an online report in the journal Nature.

6 Nov 2008